Titin Isoform Switch in Ischemic Human Heart Disease

Background—Ischemia-induced cardiomyopathy usually is accompanied by elevated left ventricular end-diastolic pressure, which follows from increased myocardial stiffness resulting from upregulated collagen expression. In addition to collagen, a main determinant of stiffness is titin, whose role in ischemia-induced left ventricular stiffening was studied here. Human heart sarcomeres coexpress 2 principal titin isoforms, a more compliant N2BA isoform and a stiffer N2B isoform. In comparison, normal rat hearts express almost no N2BA titin. Methods and Results—Gel electrophoresis and immunoblotting were used to determine the N2BA-to-N2B titin isoform ratio in nonischemic human hearts and nonnecrotic left ventricle of coronary artery disease (CAD) patients. The average N2BA-to-N2B ratio was 47:53 in severely diseased CAD transplanted hearts and 32:68 in nonischemic transplants. In normal donor hearts and donor hearts with CAD background, relative N2BA titin content was ≈30%. The titin isoform shift in CAD transplant hearts coincided with a high degree of modifications of cardiac troponin I, probably indicating increased preload. Immunofluorescence microscopy on CAD transplant specimens showed a regular cross-striated arrangement of titin and increased expression of collagen and desmin. Force measurements on isolated myofibrils revealed reduced passive-tension levels in sarcomeres of CAD hearts with high left ventricular end-diastolic pressure compared with sarcomeres of normal hearts. In a rat model of ischemia-induced myocardial infarction (left anterior descending coronary artery ligature), 43% of animals, but only 14% of sham-operated animals, showed a distinct N2BA titin band on gels. Conclusions—A titin isoform switch was observed in chronically ischemic human hearts showing extensive remodeling, which necessitated cardiac transplantation. The shift, also confirmed in rat hearts, caused reduced titin-derived myofibrillar stiffness. Titin modifications in long-term ischemic myocardium could impair the ability of the heart to use the Frank-Starling mechanism.

[1]  W. Linke,et al.  The Giant Protein Titin: Emerging Roles in Physiology and Pathophysiology , 1997 .

[2]  A. Friedl,et al.  Altered expression of titin and contractile proteins in failing human myocardium. , 1994, Journal of molecular and cellular cardiology.

[3]  M. Böhm,et al.  Molecular aspects of adrenergic signal transduction in cardiac failure , 1998, Journal of Molecular Medicine.

[4]  V. Gil.  [Hibernating myocardium. An incomplete adaptation to ischemia]. , 1998, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[5]  P. Tombe.  Altered contractile function in heart failure , 1998 .

[6]  H. Granzier,et al.  Cardiac titin isoforms are coexpressed in the half-sarcomere and extend independently. , 2001, American journal of physiology. Heart and circulatory physiology.

[7]  K. Weber,et al.  Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. , 1997, Circulation.

[8]  Wolfgang A. Linke,et al.  Reverse engineering of the giant muscle protein titin , 2002, Nature.

[9]  D. Atar,et al.  Role of troponin I proteolysis in the pathogenesis of stunned myocardium. , 1997, Circulation research.

[10]  T Centner,et al.  Series of exon-skipping events in the elastic spring region of titin as the structural basis for myofibrillar elastic diversity. , 2000, Circulation research.

[11]  J. Lüdemann,et al.  Existence of the Frank-Starling mechanism in the failing human heart. Investigations on the organ, tissue, and sarcomere levels. , 1996, Circulation.

[12]  R. Moss,et al.  Titin: an elastic link between length and active force production in myocardium. , 2001, Circulation.

[13]  M. Böhm,et al.  Titin, myosin light chains and C-protein in the developing and failing human heart. , 1994, Journal of molecular and cellular cardiology.

[14]  M. LeWinter,et al.  Alterations in the determinants of diastolic suction during pacing tachycardia. , 2000, Circulation research.

[15]  W. Linke,et al.  Interaction Between PEVK-Titin and Actin Filaments: Origin of a Viscous Force Component in Cardiac Myofibrils , 2001, Circulation research.

[16]  J. Schaper,et al.  The role of the cytoskeleton in heart failure. , 2000, Cardiovascular research.

[17]  J. Trinick,et al.  Does titin regulate the length of muscle thick filaments? , 1989, Journal of molecular biology.

[18]  T. Irving,et al.  Passive tension in cardiac muscle: contribution of collagen, titin, microtubules, and intermediate filaments. , 1995, Biophysical journal.

[19]  J. Canty,et al.  Preload Induces Troponin I Degradation Independently of Myocardial Ischemia , 2001, Circulation.

[20]  Wolfgang A. Linke,et al.  I-Band Titin in Cardiac Muscle Is a Three-Element Molecular Spring and Is Critical for Maintaining Thin Filament Structure , 1999, The Journal of cell biology.

[21]  P. D. de Tombe,et al.  Losartan prevents contractile dysfunction in rat myocardium after left ventricular myocardial infarction. , 2001, American journal of physiology. Heart and circulatory physiology.

[22]  D. K. Arrell,et al.  Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury. , 1999, Circulation research.

[23]  G H Pollack,et al.  Passive and active tension in single cardiac myofibrils. , 1994, Biophysical journal.